These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25946357)

  • 1. The fourth national anti-tuberculosis drug resistance survey in Viet Nam.
    Nhung NV; Hoa NB; Sy DN; Hennig CM; Dean AS
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):670-5. PubMed ID: 25946357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey.
    Menzies HJ; Moalosi G; Anisimova V; Gammino V; Sentle C; Bachhuber MA; Bile E; Radisowa K; Kachuwaire O; Basotli J; Maribe T; Makombe R; Shepherd J; Kim B; Samandari T; El-Halabi S; Chirenda J; Cain KP
    Int J Tuberc Lung Dis; 2014 Sep; 18(9):1026-33. PubMed ID: 25189548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
    Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P
    Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.
    Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT
    Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of tuberculosis drug resistance among Tibetan refugees in India.
    Salvo F; Dorjee K; Dierberg K; Cronin W; Sadutshang TD; Migliori GB; Rodrigues C; Trentini F; Di Serio C; Chaisson R; Cirillo DM
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):655-62. PubMed ID: 24903934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
    Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R
    BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey.
    Kamolwat P; Nateniyom S; Chaiprasert A; Disratthakit A; Mahasirimongkol S; Yamada N; Smithtikarn S
    Trop Med Int Health; 2021 Jan; 26(1):45-53. PubMed ID: 32997863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tuberculosis drug resistance in Bangladesh: reflections from the first nationwide survey.
    Kamal SM; Hossain A; Sultana S; Begum V; Haque N; Ahmed J; Rahman TM; Hyder KA; Hossain S; Rahman M; Ahsan CR; Aung KJ; Islam A; Hasan R; Van Deun A
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):151-6. PubMed ID: 25574912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.
    Forson A; Kwara A; Kudzawu S; Omari M; Otu J; Gehre F; de Jong B; Antonio M
    BMC Infect Dis; 2018 Apr; 18(1):149. PubMed ID: 29606091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second nationwide anti-tuberculosis drug resistance survey in Namibia.
    Ruswa N; Mavhunga F; Roscoe JC; Beukes A; Shipiki E; van Gorkom J; Sawadogo S; Agolory S; Menzies H; Tiruneh D; Makumbi B; Bayer B; Zezai A; Campbell P; Alexander H; Kalisvaart N; Forster N
    Int J Tuberc Lung Dis; 2019 Jul; 23(7):858-864. PubMed ID: 31439119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
    Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
    Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
    Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
    Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
    BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Xpert(®) MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan.
    Tahseen S; Qadeer E; Khanzada FM; Rizvi AH; Dean A; Van Deun A; Zignol M
    Int J Tuberc Lung Dis; 2016 Apr; 20(4):448-55. PubMed ID: 26970152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
    BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of Mycobacterium tuberculosis isolates lacking IS6110 in Viet Nam.
    Huyen MN; Tiemersma EW; Kremer K; de Haas P; Lan NT; Buu TN; Sola C; Cobelens FG; van Soolingen D
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1479-85. PubMed ID: 24125454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.
    Qi W; Harries AD; Hinderaker SG
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):137-9. PubMed ID: 21276311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center.
    Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y
    Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.